Roger D. Weiss, M.D., is Professor of Psychiatry at Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse at McLean Hospital in Belmont, Massachusetts. His career has focused on treatment and clinical research with substance-dependent patients, particularly those with co-occurring psychiatric illness. He has been Principal Investigator on numerous NIDA or NIAAA grants, and has developed Integrated Group Therapy, an evidence-based treatment for patients with co-occurring bipolar disorder and substance use disorders. Dr. Weiss recently led a multi-site national study of the treatment of prescription opioid dependence, as part of the NIDA Clinical Trials Network. He has authored over 300 articles and book chapters as well as 2 books, and has participated in a number of prominent national committees, including serving as Vice Chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders. He was named a Member of Honor by the Spanish Society for Dual Disorders in 2011, and has received numerous other awards, including the H. David Archibald Award for Outstanding Research and/or Practice in the Addictions from The Centre for Addiction and Mental Health in Toronto (2007), the Jack H. Mendelson Research Award from McLean Hospital (2012), and the Dan Anderson Research Award from the Hazelden Foundation (2012).
To contact GME, email us at [email protected]